Currently submitted to: JMIR Research Protocols
Date Submitted: Apr 21, 2026
Open Peer Review Period: Apr 22, 2026 - Jun 17, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Development And Feature Analysis of YenQuit App: A Smoking Cessation Tool Amongst Health Care Professional Students: Protocol for a cross-sectional study
ABSTRACT
Background:
Health care professional students represent as important target group for tobacco control interventions, as the behaviour established during their training years may influence both their future personal health practice and also their role in cessation counselling to patients. In recent years, mobile health (mHealth) has emerged as promising tool in tobacco cessation by providing accessible, personalized support, progress tracking and real time interventions. However, there is limited evidence on the specific design, personalized support. The Yenquit Application was developed based on 5As and 5Rs to address this gap by integrating user engagement feature aim to facilitate tobacco cessation.
Objective:
The objective of this study is to develop the YenQuit mobile/web-based application and aims to evaluate its features, effectiveness in promoting smoking cessation, and user engagement and experience among healthcare professional students.
Methods:
This study is a cross-sectional study. A total of 97 health care professional students that meet the inclusion criteria will have access to application, where they will fill the baseline questionnaire followed by Fagerström Test for Nicotine Dependence (FTND), Usage of application is monitored and end of 30 days of on boarding, the participants will fill the feedback on the effectiveness of the application.
Results:
: Enrollment started in March 2026. It is estimated that the enrollment period will be 12 months. Data collection is planned to be completed in 2027
Conclusions:
The Yenquit mobile application is been developed as a user -friendly, evidence-based digital tool to support smoking cessation among health care professional students. By integrating behavioral counselling approach such as the 5As and 5Rs models, the application has the potential to enhance accessibility to cessation support in academic health settings. Further evaluation will provide insights into its effectiveness, user engagement, and acceptability as a mobile-based cessation intervention Clinical Trial: Trial Acknowledgement Number is: REF/2026/03/127126
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.